BioSyent Inc. (BIOYF)
OTCMKTS · Delayed Price · Currency is USD
7.98
+0.15 (1.86%)
Oct 17, 2025, 3:07 PM EDT
BioSyent Market Cap
BioSyent has a market cap or net worth of $88.15 million as of October 17, 2025. Its market cap has decreased by -3.54% in one year.
Market Cap
88.15M
Enterprise Value
74.33M
Revenue
28.97M
Ranking
n/a
PE Ratio
14.56
Stock Price
$7.98
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 9.48M to 88.15M, an increase of 829.77%. That is a compound annual growth rate of 8.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 88.15M | -0.67% |
| Dec 31, 2024 | 88.75M | 8.08% |
| Dec 29, 2023 | 82.11M | 31.23% |
| Dec 30, 2022 | 62.57M | -23.01% |
| Dec 30, 2021 | 81.27M | 2.23% |
| Dec 31, 2020 | 79.49M | 24.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |